Contraceptive prevalence, any modern method in Zambia
Zambia: Contraceptive prevalence, any modern method was 47.5% in 2018. ▲ Rising
Contraceptive prevalence, any modern method in Zambia, 1992–2018
Source: Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division. Measured in % of married women ages 15-49.
Analysis
The most recent figure for contraceptive prevalence, any modern method in Zambia is 47.5%, measured in 2018. That is the highest value across all 6 years on record.
Compared with earlier readings it is up 45.3% over ten years.
Over the whole period, contraceptive prevalence, any modern method in Zambia peaked at 47.5% in 2018 and was at its lowest, 8.9%, in 1992.
Zambia ranks 55th of 113 countries on this measure, in the middle of the range.
Contraceptive prevalence, any modern method in Zambia, year by year
| Year | % of married women ages 15-49 | Change |
|---|---|---|
| 1992 | 8.9% | — |
| 1996 | 14.4% | +61.8% |
| 2002 | 25.3% | +75.7% |
| 2007 | 32.7% | +29.2% |
| 2014 | 44.8% | +37.0% |
| 2018 | 47.5% | +6.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 11.7% | 8.9% | 14.4% | 2 |
| 2000s | 29.0% | 25.3% | 32.7% | 2 |
| 2010s | 46.1% | 44.8% | 47.5% | 2 |
Countries ranked near Zambia
More health data for Zambia
- Un projection of annual infant deaths, annual growth rate -1.09 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 809.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 8,894 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 1.68 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0743 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.69 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is contraceptive prevalence, any modern method in Zambia?
- Contraceptive prevalence, any modern method in Zambia was 47.5% in 2018, according to Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division.
- What is the highest contraceptive prevalence, any modern method recorded in Zambia?
- The highest recorded value was 47.5% in 2018.
- What is the lowest contraceptive prevalence, any modern method recorded in Zambia?
- The lowest recorded value was 8.9% in 1992.
- How does Zambia rank for contraceptive prevalence, any modern method?
- Zambia ranks 55th out of 113 countries with data for 2018.
- Is contraceptive prevalence, any modern method rising or falling in Zambia?
- Over the last ten years it is up 45.3%. The long-run trend across the full record is rising.
- Where does this Zambia data come from?
- The figures come from Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as part of Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.